Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fiona Powrie, Director of the Kennedy Institute of Rheumatology is joining Wellcome as a new Governor in Jan 2018. Fiona says she’s thrilled to join Wellcome: "It’s an organisation I’ve admired since I started my research career. Through funding great scientific ideas, Wellcome is committed to promoting health around the world. It will be an honour to help deliver this goal."

Similar stories

New research uncovers pathways to prevent premature cell death

New research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKe, play a crucial role in preventing premature cell death, which can lead to serious inflammation in the body. The findings are particularly relevant for people with a mutation in the TBK1 gene who often develop multiorgan inflammation caused by excessive cell death even in the absence of any infection.